B2B SaaS / Veterinary Technology

How Vetnio Generated 21 Interested Leads in a 14-Day Veterinary Outbound Pilot

Test your market with Hyperke

21

Interested leads in pilot

4

Appointments booked

14 days

Initial test period

Hyperke Case Study

Vetnio

B2B SaaS / Veterinary Technology

Vetnio sells an AI documentation assistant to veterinary practices. Its product helps vets spend less time writing clinical notes, but its sales motion is not a simple software demo. A practice owner, clinic manager, and receptionist can all respond to the same email, yet only some can evaluate or adopt a new clinical workflow.

Vetnio wanted a repeatable way to reach those practices across European markets. Instead of assuming one outreach message would work everywhere, Hyperke started with a two-week market test and used the resulting conversations to identify the next constraint.

A good product message was not enough

Vetnio's proposition was specific: give veterinarians back roughly 30 to 60 minutes a day by reducing the time spent on consultation notes and documentation. That was the product benefit Vetnio brought to the campaign, not an outcome attributed to Hyperke.

The company wanted to reach veterinary practice decision-makers in several countries while protecting existing relationships and its brand. Its founder, Arman, was concerned about sending from unfamiliar domains, contacting the wrong clinics, and using messages that might sound inappropriate in a local market.

Those concerns mattered because a busy veterinary clinic is not a typical software buyer. The general inbox may be screened by reception staff. Many practices have limited time to review offers. A company that sends a positive reply may still be an unsuitable prospect if it works with farm animals or runs an unrelated animal service.

The first test: evidence of interest, but a conversion gap

Hyperke launched a 14-day, Europe-first pilot with localized outreach and an initial plan to reach up to 10,000 contacts. The team assembled veterinary contacts from industry directories, practice websites, and research beyond the generic clinic inbox wherever possible.

The pilot generated 21 interested leads and four booked appointments. These are separate stages. An interested response did not necessarily mean a qualified decision-maker or a booked sales meeting.

At the review call, the parties discussed the market-level differences. Arman described about ten interested Spanish leads, with three reaching an appointment. In the UK, five interested replies had not produced a meeting at that point. Some of the UK responses were not from suitable practices or the relevant decision-maker.

What the pilot showedWhy it matteredNext decision
Interest did not reliably become appointmentsMore replies alone would not achieve Vetnio's customer goalMove reply handling and follow-up closer to Hyperke's operation
Some leads were reception staff or unsuitable clinicsA positive response was not the same as a qualified buyerTighten clinic and decision-maker qualification
Spain was producing meetings; UK and DACH had different obstaclesThe same follow-up process could not serve every market equally wellUse regional calendars, language-appropriate responses, and separate tests
DACH feedback flagged language and cadence concernsLiteral translation could weaken trust with local buyersTest copy written by the local representative and extend spacing between touches
Generic sender identities raised concernsSender credibility affected the client's comfort with scalingPlan Vetnio-branded alternate sending domains, subject to approval

Market figures in the review were discussed verbally and should be treated as approximate. The 21-lead and four-appointment figures cover the 14-day pilot.

What changed after the review

1. Treat every positive reply as the start of a sales process. Previously, some interested responses were passed to Vetnio's representatives for follow-up. In the review, the team identified the handoff as a source of lost momentum. The next plan assigned Hyperke more responsibility for replying, following up, and helping interested clinics reach a booking decision.

2. Give every market its own conversion path. Spain already had a regional calendar. The parties planned a separate DACH calendar, while UK and US prospects could use Arman's schedule. This reduced the number of manual handoffs between an interested clinic and the representative who could run the call.

3. Adapt language and pacing to the buyer. The DACH representative raised concerns that the translated emails did not sound natural for the region and that three-day follow-ups were too frequent. The team discussed testing emails written by the local representative and extending spacing to about six days. This was a response to local market feedback, not proof that the revised campaign had already outperformed the first one.

4. Use calls only after the clinic has shown interest. For English-speaking markets, the team proposed calling warm responders from appropriate local numbers to confirm interest and arrange appointments. That was not a proposal to cold-call every veterinary clinic.

5. Separate cold market validation from partner-assisted introductions. Vetnio also had access to roughly 1,500 Belgian clinics through a practice-software relationship. The parties considered a campaign for that list, but recognized it was warmer than the cold outbound audience. Its results should not be used to inflate the measured performance of the original pilot.

The operating model behind the changes

Hyperke did not need one universal email for every veterinary market. It needed a repeatable way to discover appropriate clinics, find a reachable person, present a specific clinical benefit, test how that market responds, and identify where the resulting opportunity stops moving forward.

The sequence of decisions matters more than the list of tools. The first pilot established that some clinics would respond. The review then identified three practical problems: qualification, local credibility, and conversion after the reply. The next operating plan addressed those problems separately.

This is how the same acquisition process can transfer between industries without copying the same campaign. In Ossus's education market, the main issue was finding school contacts and managing more demo demand than the calendar could absorb. In Vetnio's veterinary market, the first issue was turning clinic interest into conversations with the right representative, in the right language.

What the evidence proves, and what it does not

The verified pilot result is 21 interested leads and four booked appointments in 14 days. It demonstrates that targeted outbound generated initial interest in Vetnio's product and exposed specific problems in the sales handoff.

The later actions described above come from the post-pilot plan and review discussion. They are not presented as a verified uplift in qualified meetings, trials, customers, or revenue. We have not established a consistent before-and-after conversion rate for the revised process.

That distinction matters. It is easy to publish the number of positive replies and imply the entire acquisition model was proven. The stronger conclusion is more precise: the initial test gave the teams enough information to change what they targeted, how they communicated, and how they converted interested buyers.

When this model is likely to transfer

The approach fits B2B products with a clear operational benefit, a reachable set of organizations, and a practical path from interest to a trial or sales conversation. It is especially useful when market knowledge must be combined with specialized data sourcing or local representatives.

It is less suitable when there is no clear buyer, when positive responses cannot be qualified, or when the client cannot support the required sales follow-up. In regulated or sensitive markets, messaging and sending practices also need appropriate local review.

The lesson from Vetnio is not that every pilot scales automatically. It is that a controlled pilot can reveal actual buyer demand and the conditions that must be solved before scaling. For a prospective customer, that is a more credible starting point than promising a fixed number of meetings before testing the market.


Want more results like these? Add Hyperke as a preferred source on Google.

FAQ’s

Common Questions

No. Vetnio's two-week pilot produced 21 interested leads and four booked appointments. We report these separately because not every positive reply is a qualified buyer or a meeting.

7-Day Pilot

Test Your Market Before a Full Engagement

For companies that qualify, we start with a pilot campaign.

In 7 days: We test your market, offer, and messaging with real prospects. If the model works, we scale it into a full outbound engine. If it does not, you know before committing to a larger program.

Apply for a No Risk Pilot Campaign